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Abstract
Priority setting is inevitable on the path towards universal health coverage. All countries experience a gap between
their population’s health needs and what is economically feasible for governments to provide. Can priority setting
ever be fair and ethically acceptable? Fairness requires that unmet health needs be addressed, but in a fair order.
Three criteria for priority setting are widely accepted among ethicists: cost-effectiveness, priority to the worse-off,
and financial risk protection. Thus, a fair health system will expand coverage for cost-effective services and give
extra priority to those benefiting the worse-off, whilst at the same time providing high financial risk protection.
It is considered unacceptable to treat people differently according to their gender, race, ethnicity, religion, sexual
orientation, social status, or place of residence. Inequalities in health outcomes associated with such personal
characteristics are therefore unfair and should be minimized. This commentary also discusses a third group of
contested criteria, including rare diseases, small health benefits, age, and personal responsibility for health, subsequently
rejecting them. In conclusion, countries need to agree on criteria and establish transparent and fair priority
setting processes.
Keywords: Ethics, Priority setting, Global health, Universal health coverage, Health technology assessment, Health
economics
Background
Worldwide, people now have a reasonable expectation
of living long and healthy lives [1]. Avoiding premature
mortality is no longer impossible for the majority of
people in high-income countries, while the bottom billion
still lag behind [2, 3]. In 2015, UN Member States signed
Sustainable Development Goal 3: Good health and well-
being. The most important sub-target and instrument to
reach the remaining targets is universal health coverage
(UHC). The Director General of the World Health
Organization (WHO) recently said that “UHC is the ul-
timate expression of fairness” and defined it as “ensuring
that everyone can obtain essential health services of high
quality without suffering financial hardship” [4].
This is a radical message – given resource constraints,
essential health services cannot entail all possible ser-
vices but rather a comprehensive range of key services
that are well-aligned with other social goals. Priority set-
ting is therefore unavoidable on the path to UHC. Most
ethicists even argue that it is unethical to ignore it; in-
deed, since healthcare needs exceed resource availability,
not setting priorities may lead to unfairness. Priority set-
ting ranks services according to their importance and
will therefore, by necessity, determine the distribution of
services in such a way that it creates winners and losers.
How is this done?
WHO and the World Bank have championed cost-
effectiveness as a key criterion for global and national
priority setting [5, 6]. In the UK, the National Institute
for Health and Care Excellence (NICE) identifies the
most cost-effective services through health technology
assessment, aiming to be open and accountable whilst
taking social value judgments into consideration, as rec-
ommended by their Citizen’s Council. Priorities are then
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implemented through clinical practice guidelines and reim-
bursement rules [7]. In Thailand, the Health Intervention
and Technology Assessment Program (HITAP) appraises a
wide range of health technologies and public health pro-
grams by six criteria: size of the population affected, severity
of the disease, effectiveness of health interventions, vari-
ation in practice, economic impact on household expend-
iture, and equity and social implications [8]. In some Latin
American countries, including Colombia, Brazil, and Costa
Rica, the courts have intervened and ruled that the right to
health or healthcare should be the overriding concern [9].
In the US and Germany, comparative effectiveness analysis
is widely performed, but cost-effectiveness analysis is not
accepted or is seen as unethical [10, 11].
Needless to say, priority setting decisions are contro-
versial in all countries, highlighting the need for clarity
and further agreement with regards to priority-setting
criteria and processes. The present commentary aims to
describe and discuss criteria for fair and ethical priority
setting, building on two guidance documents developed
by ethicists, economists, health policy experts, and pub-
lic health and clinical doctors [12, 13]; nevertheless, the
views expressed here are my own. The commentary lists
three widely accepted cross-cutting criteria and a group
of largely unaccepted criteria for priority setting (Table 1),
followed by a discussion and rejection of a group of con-
tested criteria. Finally, it argues that countries need trans-
parent processes for priority setting.
Discussion
Priority setting occurs at the macro-, meso-, and micro-
level of decision making, with a multitude of criteria that
could be relevant and have different weights at the vari-
ous levels.
Three widely accepted criteria for ethical priority setting
There is agreement among ethical theories that priority
setting should be impartial and treat people as equals.
There is growing consensus that the aims should be to
promote health maximization, fair distribution, and
protection against poverty [12, 13]. From these guiding
principles three criteria for ethical priority setting arise,
namely (1) cost-effectiveness, (2) priority to the worse-
off, and (3) financial risk protection.
Choosing priority services based on the cost-effectiveness
of new interventions compared to current standard is im-
portant considering that improving the length and quality
of life has both direct and indirect value for people. Even if
cost-effectiveness is not accepted in Germany and the US,
there are very few ethicists who would argue that this cri-
terion is not at all relevant – to not improve health as much
as possible would have substantial opportunity costs in
terms of healthy life years forgone [14]. In addition, the
most cost-effective services often benefit the worse-off and
provide the most financial risk protection, although this is
not always the case. However, cost-effectiveness cannot be
the only criterion.
Priority to the worse-off is important since benefiting
them matters more than those who are better-off and
would reduce unfair inequalities [15]. The worse-off can
be defined as those with the most severe and large indi-
vidual disease burden, or the poorest or otherwise disad-
vantaged [13]. Since the most cost-effective services do
not always benefit the worse-off, services targeting the
worse-off should be assigned extra value.
Financial risk protection is important, especially in low-
income settings, since disease may cause substantial loss
of income or because out-of-pocket expenditure for health
services may impoverish people [16]. In cases where less
cost-effective services may provide very high financial
protection, such services should be given extra priority.
Unacceptable criteria
There is agreement among ethical theories about un-
acceptable criteria for priority setting. Even if these are
widely used in practice, it is not considered acceptable
to treat people differently according to their gender, race,
ethnicity, religion, sexual orientation, social status, or
area of residence [12, 13]. These criteria are ethically un-
acceptable since they are morally irrelevant and priority
setting should only take relevant criteria into consider-
ation; health outcome inequalities associated with such
personal characteristics are therefore unfair and should
be minimized.
Contested criteria
There is a long list of additional criteria where there is
less consensus and where countries may vary with regards
to the social value judgments they make.
The size of the population affected is an often pro-
posed criterion, at times assigning higher priority to rare
diseases and at others to common diseases (large aggre-
gate disease burden). My response is that prevalence is
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not ethically relevant. Since it is hard to develop treatments
for rare diseases, many countries (rightly so) require less
strict documentation of evidence for effectiveness. How-
ever, the ethical importance of services for rare and very
common diseases is captured by the three accepted criteria
discussed above.
Some have argued that very small benefits for non-se-
vere conditions are morally “irrelevant” and should not be
aggregated and compared to large benefits for few people
[17]. My response is that all health benefits are relevant. If
curing a headache is morally irrelevant, it would never get
priority. Cost-effectiveness balanced against priority for
the worse-off would, for all practical purposes, capture
what is ethically relevant.
Age is sometimes used in prioritizing between patients
for scarce organ transplants, but is rarely recommended
at the group level as a criterion in itself. Some argue that
the indirect effect of using cost-effectiveness and priority
to the worse-off is age discriminatory. My response is
that there are no age-neutral principles for priority set-
ting in health since a long lifespan is inherent in the def-
inition of health. If we aim to improve healthy life
expectancy and reduce inequality in longevity, the young
will typically benefit first. This is also ethically acceptable
[18]; however, age itself should not be a criterion.
Some argue that patients who are responsible for their
poor health status due to their freely chosen lifestyle
should be given lower priority than others. My response
is that society’s primary responsibility is to enable equal
opportunities through health service provision and fair
distribution of the determinants of health. The expected
external cost of choice can be covered through taxes
(e.g., tobacco) without making people responsible for the
outcome of their choices [19].
Finally, comorbidity, the occurrence of two or more
conditions at the same time, is often seen as a challenge
for priority setting at the clinical level. Should the pres-
ence of dementia count when assessing priority for pa-
tients in need of advanced chemotherapy for cancer?
Should metastatic cancer count when assessing priority
for patients in need of a heart transplant? Comorbidity
may reduce the overall effect and value of such treat-
ment. My response is that all medically relevant facts
should be carefully considered and that comorbidity may
make a patient worse-off than others and count in that
patient’s favor, but must be balanced against the reduced
effect and cost-effectiveness of the service; indeed, a
heart transplant would be wasted if the patient is likely
to die of terminal cancer a month later.
The role of fair processes
Some argue that all substantive criteria for priority set-
ting are so contested that they should be replaced by a
fair and legitimate process. My response is that both
process and substantive judgments are important. “Ac-
countability for Reasonableness” is a widely accepted
framework that sets out conditions for a legitimate pri-
ority setting process [20]. The core idea is that govern-
ments or other providers should make explicit the range
of services they offer, and that reasons for inclusion or
exclusion are made transparent to all affected parties. A
fair process is inclusive and has broad stakeholder in-
volvement and mechanisms for critical assessment and
revision. The process itself should be institutionalized. If
satisfied, these conditions can connect decisions about
priority setting to broader democratic processes [18].
Future directions and conclusions
Priority setting is inevitable on the path towards UHC
and better population health. There is growing consensus
regarding the three key criteria for ethical priority setting,
namely cost-effectiveness, priority to the worse-off, and fi-
nancial risk protection. Herein, it is argued that other, con-
tested criteria are unnecessary or unacceptable, but that
countries need transparent, legitimate processes for prior-
ity setting. A suitable starting point would be to establish a
global priority setting commission, as well as commissions
at the national level, to develop guidelines for efficient and
fair priority setting.
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